What question did this study set out to answer?

The aim is to explore the complexities and treatment challenges associated with a rare case of maxillary sinus carcinoma.

February 9, 2026Current Issues in Pharmacy and Medical Sciences0 citationsOpen Access

Navigating the uncharted territory of aggressive maxillary sinus cancer: insights from a singular case

KGKatarzyna Gęca DKDorota Kozaczuk WPWojciech Polkowski

Key Points

The aim is to explore the complexities and treatment challenges associated with a rare case of maxillary sinus carcinoma.
Described a singular case of aggressive maxillary sinus carcinoma in a 57-year-old male.
Utilized multimodal treatments including surgery, radiochemotherapy, and palliative chemotherapy.
Emphasized a patient-centered approach and shared decision-making during treatment.
The disease exhibited rapid progression despite aggressive multimodal treatment.
The patient showed resistance to standard therapeutic approaches.
The case emphasizes the necessity for individualized care in managing rare head and neck cancers.

Abstract

Maxillary sinus carcinoma (MSC) is a rare malignancy characterized by diagnostic and therapeutic complexity, often presenting late in its clinical course. This report details a unique and aggressive case of MSC in a 57-year-old male. Despite prompt multimodal treatment, including surgery, radiochemotherapy (RCTH) and sequential lines of palliative chemotherapy (CTH), the disease demonstrated rapid progression and resistance to standard therapies. Management was guided by a patient-centered approach, emphasizing shared decision-making in light of the patient’s clinical trajectory and quality-of-life considerations. This case highlights the challenges of treating aggressive MSC and underscores the necessity for individualized care strategies in managing rare and refractory head and neck cancers.

AIに質問

Bookmark

View Full Paper